Hereditary transthyretin-mediated amyloidosis
Genetic Disorder
Hereditary transthyretin-mediated amyloidosis is treated with 1 medication in our database, including TRYNGOLZA. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Alnylam Pharmaceuticals. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Hereditary transthyretin-mediated amyloidosis treatment below.
What help exists for Hereditary transthyretin-mediated amyloidosis
3
drugs indexed
3
with copay cards
3
with patient assistance
1
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Hereditary transthyretin-mediated amyloidosis
3 totalOnpattro
patisiran · Alnylam
🎟💙TRYNGOLZA
olezarsen sodium · Alnylam Pharmaceuticals
🎟💙AMVUTTRA
VUTRISIRAN · Alnylam
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Hereditary transthyretin-mediated amyloidosis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |